Skip to main content
SpringerLink
Log in

Pulmonary Complications

  • Chapter
  • First Online:
Infections in Hematology

  • 1542 Accesses

Abstract

Up to 25 % of patients with profound neutropenia lasting for >10 days develop lung infiltrates, which are frequently refractory to broad-spectrum antibacterial therapy. While a causative pathogen remains undetected in the majority of cases, Aspergillus spp., Pneumocystis jirovecii, multiresistant gram-negative pathogens, mycobacteria, or respiratory viruses frequently are involved. In patients who have received trimethoprim-sulfamethoxazole prophylaxis, filamentous fungal pathogens appear to be predominant, yet commonly not microbiologically proven at the time of treatment initiation. Preemptive treatment with mold-active systemic antifungal agents such as voriconazole and liposomal amphotericin B improves clinical outcome, while other microorganisms are preferably treated only when microbiologically documented. Pathogens isolated from blood cultures, bronchoalveolar lavage, or respiratory secretions are not necessarily relevant for the etiology of pulmonary infiltrates and should therefore be interpreted with caution. Laboratory tests for detecting circulating fungal antigens such as Aspergillus galactomannan assay, beta-D-glucan or fungal DNA testing from blood, bronchoalveolar lavage, or tissue specimen testing may facilitate the diagnosis; however, PCR techniques are not yet standardized and validated. High-dose trimethoprim-sulfamethoxazole is the first choice for the treatment of Pneumocystis pneumonia, while cytomegalovirus pneumonia is treated primarily with ganciclovir in most patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ahmed S, Siddiqui AK, Rossoff L, Sison CP, Rai KR. Pulmonary complications in chronic lymphocytic leukemia. Cancer. 2003;98:1912–7.

    PubMed  Google Scholar 

  2. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur J Clin Microbiol Infect Dis. 2007;26:13–20.

    CAS  PubMed  Google Scholar 

  3. Akova M, Paesmans M, Calandra T, Viscoli C. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis. 2005;40:239–45.

    PubMed  Google Scholar 

  4. Al Ameri A, Koller C, Kantarjian H, et al. Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116:93–7.

    PubMed  Google Scholar 

  5. Alanio A, Desoubeaux G, Sarfati C, et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect. 2011;17:1531–7.

    CAS  PubMed  Google Scholar 

  6. Armenian SH, La Via WV, Siegel SE, Mascarenhas L. Evaluation of persistent pulmonary infiltrates in pediatric oncology patients. Pediatr Blood Cancer. 2007;48:165–72.

    PubMed  Google Scholar 

  7. Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol. 2006;44:389–94.

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135:655–61.

    CAS  PubMed  Google Scholar 

  9. Azoulay E, Darmon M, Delclaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med. 2002;30:781–6.

    PubMed  Google Scholar 

  10. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182:1038–46.

    PubMed  Google Scholar 

  11. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure. Crit Care Med. 2008;36:100–7.

    PubMed  Google Scholar 

  12. Azoulay E, Thiery G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine. 2004;83:360–70.

    PubMed  Google Scholar 

  13. Becker MJ, Lugtenburg EJ, Cornelissen JJ, et al. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol. 2003;121:448–57.

    CAS  PubMed  Google Scholar 

  14. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis. 1992;11:99–109.

    CAS  PubMed  Google Scholar 

  15. Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematol Am Soc Hematol Educ Program. 2011;2011:305–9.

    Google Scholar 

  16. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol. 2008;143:455–67.

    PubMed Central  PubMed  Google Scholar 

  17. Boersma WG, Erjavec Z, van der Werf TS, et al. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med. 2007;101:317–25.

    PubMed  Google Scholar 

  18. Böhme A, Ruhnke M, Buchheidt D, et al. Treatment of invasive fungal infections in cancer patients. Ann Hematol. 2009;88:97–110.

    PubMed  Google Scholar 

  19. Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis. 2010;42:461–8.

    CAS  PubMed  Google Scholar 

  20. Brodoefel H, Vogel M, Hebart H, et al. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis. Am J Roentgenol. 2006;187:404–13.

    Google Scholar 

  21. Buchheidt D, Baust C, Skladny H, et al. Detection of aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis. 2001;33:428–35.

    CAS  PubMed  Google Scholar 

  22. Burghi G, Lemiale V, Seguin A, et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med. 2011;37:1605–12.

    PubMed  Google Scholar 

  23. Busca A, Locatelli F, Barbui A, et al. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. Transplant Proc. 2006;38:1610–3.

    CAS  PubMed  Google Scholar 

  24. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15:139–47.

    CAS  PubMed  Google Scholar 

  25. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001;19:253–9.

    CAS  PubMed  Google Scholar 

  26. Caillot D, Latrabe V, Thiébaut A, et al. Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: a useful tool for diagnosis and assessment of outcome in clinical trials. Eur J Radiol. 2010;74:e172–5.

    PubMed  Google Scholar 

  27. Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect. 2001;7 Suppl 2:54–61.

    PubMed  Google Scholar 

  28. Camus P, Costabel U. Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med. 2005;26:458–81.

    PubMed  Google Scholar 

  29. Carrafiello G, Lagana D, Nosari AM, et al. Utility of computed tomography and of fine needle aspiration biopsy in early diagnosis of fungal pulmonary infections. Radiol Med. 2006;111:33–41.

    CAS  PubMed  Google Scholar 

  30. Carroll KC, Cohen S, Nelson R, et al. Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis. 1998;32:229–35.

    CAS  PubMed  Google Scholar 

  31. Cazzadori A, di Perri G, Todeschini G, et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest. 1995;107:101–6.

    CAS  PubMed  Google Scholar 

  32. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006;91:986–9.

    PubMed  Google Scholar 

  33. Chemaly RF, Hanmod SS, Rathod DB, et al. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012;119:2738–45.

    CAS  PubMed  Google Scholar 

  34. Chemaly RF, Torres HA, Aguilera EA, et al. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007;44:964–7.

    PubMed  Google Scholar 

  35. Cherif H, Martling CR, Hansen J, Kalin M, Björkholm M. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Support Care Cancer. 2007;15:1393–8.

    PubMed  Google Scholar 

  36. Clark BD, Vezza PR, Copeland C, Wilder AM, Abati A. Diagnostic sensitivity of bronchoalveolar lavage versus fine needle aspirate. Mod Pathol. 2002;15:1259–65.

    PubMed  Google Scholar 

  37. Cornely OA, Maertens J, Bresnik M, et al. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease. Mycoses. 2011;54:e449–55.

    PubMed  Google Scholar 

  38. Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43:577–84.

    CAS  PubMed  Google Scholar 

  39. Danés C, Gonzalez-Martin J, Pumarola T, et al. Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol. J Clin Microbiol. 2002;40:2134–40.

    PubMed Central  PubMed  Google Scholar 

  40. Daniels CE, Myers JL, Utz JP, Markovic SN, Ryu JH. Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion. Respir Med. 2007;101:162–8.

    PubMed  Google Scholar 

  41. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group Consensus Group. Clin Infect Dis. 2008;46:1813–21.

    PubMed Central  PubMed  Google Scholar 

  42. Debur MC, Vidal LR, Stroparo E, et al. Human metapneumovirus infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2010;12:173–9.

    CAS  PubMed  Google Scholar 

  43. Delclaux C, Zahar JR, Amraoui G, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients. Clin Infect Dis. 1999;29:670–2.

    CAS  PubMed  Google Scholar 

  44. Dettenkofer M, Wenzler-Rottele S, Babikir R, et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant. Clin Infect Dis. 2005;40:926–31.

    CAS  PubMed  Google Scholar 

  45. Donhuijsen K, Pfaffenbach B, Samandari S, Leder LD. Autopsy results of deep mycoses in hematologic neoplasms. Mycoses. 1991;34(Suppl):25–7.

    PubMed  Google Scholar 

  46. Eibel R, Herzog P, Dietrich O, et al. Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology. 2006;241:880–91.

    PubMed  Google Scholar 

  47. Einsele H, Hebart H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol. 1997;35:1353–60.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Ellis ME, Spence D, Bouchama A, et al. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Scand J Infect Dis. 1995;27:157–62.

    CAS  PubMed  Google Scholar 

  49. Escuissato DL, Gasparetto EL, Marchiori E, et al. Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients. Am J Roentgenol. 2005;185:608–15.

    Google Scholar 

  50. Ewig S, Glasmacher A, Ulrich B, et al. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy. Chest. 1998;114:444–51.

    CAS  PubMed  Google Scholar 

  51. Faguer S, Kamar N, Fillola G, Guitard J, Rostaing L. Linezolid-related pancytopenia in organ-transplant patients: report of two cases. Infection. 2007;35:275–7.

    CAS  PubMed  Google Scholar 

  52. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory Syncytial Virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–59.

    CAS  PubMed  Google Scholar 

  53. Fassas AB, Bolaños-Meade J, Buddharaju LN, et al. Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. Br J Haematol. 2001;112:237–41.

    CAS  PubMed  Google Scholar 

  54. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med. 2007;35:1888–95.

    CAS  PubMed  Google Scholar 

  55. Gasparetto EL, Escuissato DL, Marchiori E, et al. High-resolution CT findings of respiratory syncytial virus pneumonia after bone marrow transplantation. Am J Roentgenol. 2004;182:1133–7.

    Google Scholar 

  56. Georgiadou SP, Kontoyiannis DP. Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis? J Infect. 2012;65:262–8.

    PubMed  Google Scholar 

  57. Georgiadou SP, Sampsonas FL, Rice D, Granger JM, Swisher S, Kontoyiannis DP. Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses. Eur J Clin Microbiol Infect Dis. 2013;32:101–5.

    CAS  PubMed  Google Scholar 

  58. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52:1144–55.

    PubMed Central  PubMed  Google Scholar 

  59. Girmenia C, Santilli S, Ballarò D, Del Giudice I, Armiento D, Mauro FR. Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases. Mycoses. 2011;54:e883–4.

    PubMed  Google Scholar 

  60. Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373–9.

    PubMed  Google Scholar 

  61. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33:23–32.

    CAS  PubMed  Google Scholar 

  62. Hachem R, Sumoza D, Hanna H, Girgawy E, Munsell M, Raad I. Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group criteria be revised? Cancer. 2006;106:1581–6.

    PubMed  Google Scholar 

  63. Hachem RY, Chemaly RF, Ahmar CA, et al. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother. 2007;51:1905–11.

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Hage CA, Reynolds JM, Durkin M, Wheat LJ, Knox KS. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol. 2007;45:676–7.

    PubMed Central  PubMed  Google Scholar 

  65. Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. Am J Roentgenol. 1997;169:1347–53.

    CAS  Google Scholar 

  66. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol. 1999;17:796–805.

    CAS  PubMed  Google Scholar 

  67. Heussel CP, Kauczor HU, Ullmann AJ. Pneumonia in neutropenic patients. Eur Radiol. 2004;14:256–71.

    CAS  PubMed  Google Scholar 

  68. Hicks KL, Chemaly RF, Kontoyiannis DP. Common community respiratory viruses in patients with cancer: more than just “common colds”. Cancer. 2003;97:2576–87.

    PubMed  Google Scholar 

  69. Hoffer FA, Gow K, Flynn PM, Davidoff A. Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol. 2001;31:144–52.

    CAS  PubMed  Google Scholar 

  70. Hohenthal U, Itälä M, Salonen J, et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy–value of new microbiological methods. Eur J Haematol. 2005;74:203–11.

    CAS  PubMed  Google Scholar 

  71. Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 1999;94:4029–35.

    CAS  PubMed  Google Scholar 

  72. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996;100:171–8.

    CAS  PubMed  Google Scholar 

  73. Hummel M, Rudert S, Hof H, Hehlmann R, Buchheidt D. Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol. 2008;87:291–7.

    PubMed  Google Scholar 

  74. Hwang SS, Kim HH, Park SH, Jung JI, Jang HS. The value of CT-guided percutaneous needle aspiration in immunocompromised patients with suspected pulmonary infection. Am J Roentgenol. 2000;175:235–8.

    CAS  Google Scholar 

  75. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005;165:1375–80.

    PubMed  Google Scholar 

  76. Jain P, Sandur S, Meli Y, et al. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004;125:712–22.

    PubMed  Google Scholar 

  77. Kim K, Lee MH, Kim J, et al. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Am J Hematol. 2002;71:75–9.

    PubMed  Google Scholar 

  78. Korones DN. Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer? Pediatr Blood Cancer. 2004;43:715–7.

    PubMed  Google Scholar 

  79. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106:2258–66.

    PubMed  Google Scholar 

  80. Lamoth F, Cruciani M, Mengoli C, Third European Conference on Infections in Leukemia (ECIL-3), et al. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis. 2012;54:633–43.

    PubMed  Google Scholar 

  81. Lass-Flörl C, Gunsilius E, Gastl G, et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol. 2004;42:4154–7.

    PubMed Central  PubMed  Google Scholar 

  82. Lass-Flörl C, Resch G, Nachbaur D, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007;45:e101–4.

    PubMed  Google Scholar 

  83. Limper AH, Knox KS, Sarosi GA, American Thoracic Society Fungal Working Group, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96–128.

    CAS  PubMed  Google Scholar 

  84. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358–66.

    CAS  PubMed  Google Scholar 

  85. Link H, Maschmeyer G, Meyer P, et al. Interventional antimicrobial therapy in febrile neutropenic patients. Ann Hematol. 1994;69:231–43.

    CAS  PubMed  Google Scholar 

  86. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094–7.

    PubMed  Google Scholar 

  87. Ljungman P, von Dobeln L, Ringholm L, et al. The value of CMV and fungal PCR for monitoring for acute leukaemia and autologous stem cell transplant patients. Scand J Infect Dis. 2005;37:121–7.

    PubMed  Google Scholar 

  88. Luna LK, Panning M, Grywna K, Pfefferle S, Drosten C. Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis. 2007;195:675–9.

    PubMed  Google Scholar 

  89. Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection. Clin Infect Dis. 2005;41:1242–50.

    CAS  PubMed  Google Scholar 

  90. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol. 1999;37:3223–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  91. Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis. 2007;44:1329–36.

    CAS  PubMed  Google Scholar 

  92. Marcolini JA, Malik S, Suki D, Whimbey E, Bodey GP. Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis. 2003;22:79–84.

    CAS  PubMed  Google Scholar 

  93. Marr KA, Schlamm H, Rottinghaus ST, et al. A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis. 22nd European congress of Clinical Microbiology and Infectious Diseases, London, 31 Mar–3 Apr 2012, abstr # LB2812.

    Google Scholar 

  94. Martino R, Ramila E, Rabella N, et al. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36:1–8.

    PubMed  Google Scholar 

  95. Maschmeyer G, Beinert T, Buchheidt D, et al. Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients. 2008 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Oncology. Eur J Cancer. 2009;45:2462–72.

    CAS  PubMed  Google Scholar 

  96. Maschmeyer G, Bertschat FL, Moesta KT, et al. Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer. 2003;39:783–92.

    CAS  PubMed  Google Scholar 

  97. Maschmeyer G, Haas A. Defining clinical failure for salvage studies. Med Mycol. 2006;44:S315–8.

    Google Scholar 

  98. Maschmeyer G, Link H, Hiddemann W, et al. Pulmonary infiltrations in febrile neutropenic patients. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter trial. Cancer. 1994;73:2296–304.

    CAS  PubMed  Google Scholar 

  99. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:89–96.

    CAS  PubMed  Google Scholar 

  100. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care. 2005;9:R53–9.

    PubMed Central  PubMed  Google Scholar 

  101. Monneret G, Doche C, Durand DV, Lepape A, Bienvenu J. Procalcitonin as a specific marker of bacterial infection in adults. Clin Chem Lab Med. 1998;36:67–8.

    CAS  PubMed  Google Scholar 

  102. Mori T, Kato J. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int J Hematol. 2010;91:588–95.

    PubMed  Google Scholar 

  103. Mulabecirovic A, Gaulhofer P, Auner HW, et al. Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis. Ann Hematol. 2004;83:420–2.

    CAS  PubMed  Google Scholar 

  104. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol. 2004;42:5517–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  105. Nahimana A, Rabodonirina M, Zanetti G, et al. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis. 2003;188:1017–23.

    CAS  PubMed  Google Scholar 

  106. Navigante AH, Cerchietti LC, Costantini P, et al. Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia. Cancer Control. 2002;9:346–51.

    PubMed  Google Scholar 

  107. Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis. 1998;26:1098–103.

    CAS  PubMed  Google Scholar 

  108. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1,3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654–9.

    CAS  PubMed  Google Scholar 

  109. Oude Nijhuis CS, Gietema JA, Vellenga E, et al. Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patients. Eur J Cancer. 2003;39:2495–8.

    CAS  PubMed  Google Scholar 

  110. Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M. Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer. 2005;13:332–8.

    PubMed  Google Scholar 

  111. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91:1068–75.

    PubMed  Google Scholar 

  112. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study. Clin Infect Dis. 2007;45:1161–70.

    CAS  PubMed  Google Scholar 

  113. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113:1215–24.

    CAS  PubMed  Google Scholar 

  114. Park SY, Park HJ, Moon SM, et al. Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia. BMC Infect Dis. 2012;12:308.

    PubMed Central  PubMed  Google Scholar 

  115. Patel NR, Lee PS, Kim JH, Weinhouse GL, Koziel H. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest. 2005;127:1388–96.

    PubMed  Google Scholar 

  116. Paul M, Soares-Weiser K, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ. 2003;326:1111–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  117. Peikert T, Rana S, Edell ES. Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates. Mayo Clin Proc. 2005;80:1414–20.

    PubMed  Google Scholar 

  118. Post MJ, Lass-Floerl C, Gastl G, Nachbaur D. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients. Transpl Infect Dis. 2007;9:189–95.

    CAS  PubMed  Google Scholar 

  119. Raad II, Whimbey EE, Rolston KVI, et al. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer. 1996;77:1386–94.

    CAS  PubMed  Google Scholar 

  120. Rámila E, Sureda A, Martino R, et al. Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica. 2000;85:961–6.

    PubMed  Google Scholar 

  121. Reich G, Mapara MY, Reichardt P, Dörken B, Maschmeyer G. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2001;27:525–9.

    CAS  PubMed  Google Scholar 

  122. Rickerts V, Mousset S, Lambrecht E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis. 2007;44:1078–83.

    PubMed  Google Scholar 

  123. Robinson JO, Lamoth F, Bally F, Knaup M, Calandra T, Marchetti O. Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever? PLoS One. 2011;6:e18886.

    CAS  PubMed Central  PubMed  Google Scholar 

  124. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228–33.

    PubMed  Google Scholar 

  125. Rossini F, Verga M, Pioltelli P, et al. Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica. 2000;85:1255–60.

    CAS  PubMed  Google Scholar 

  126. Rossiter SJ, Miller DC, Churg AM, Carrington CB, Mark JBD. Open lung biopsy in the immunocompromised patient. Is it really beneficial? J Thorac Cardiovasc Surg. 1979;77:338–45.

    CAS  PubMed  Google Scholar 

  127. Ruhnke M, Böhme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology. Ann Oncol. 2012;23:823–33.

    CAS  PubMed  Google Scholar 

  128. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007;45:1602–9.

    PubMed  Google Scholar 

  129. Samonis G, Kontoyiannis DP. Infectious complications of purine analog therapy. Curr Opin Infect Dis. 2001;14:409–13.

    CAS  PubMed  Google Scholar 

  130. Schiel X, Link H, Maschmeyer G, et al. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients. Infection. 2006;34:118–26.

    CAS  PubMed  Google Scholar 

  131. Sculier JP. Intensive care and oncology. Support Care Cancer. 1995;3:93–105.

    CAS  PubMed  Google Scholar 

  132. Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis. 2007;44:402–9.

    PubMed  Google Scholar 

  133. Shorr AF, Susla GM, O’Grady NP. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest. 2004;125:260–71.

    PubMed  Google Scholar 

  134. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149–52.

    CAS  PubMed  Google Scholar 

  135. Sing A, Trebesius K, Roggenkamp A, et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol. 2000;38:1461–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  136. Singer C, Armstrong D, Rosen PP, Walzer PD, Yu B. Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases. Am J Med. 1979;66:110–20.

    CAS  PubMed  Google Scholar 

  137. Smego Jr RA, Nagar S, Maloba B, Popara M. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med. 2001;161:1529–33.

    CAS  PubMed  Google Scholar 

  138. Sonnet S, Buitrago-Téllez CH, Tamm M, Christen S, Steinbrich W. Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography. AJR Am J Roentgenol. 2005;184:746–51.

    PubMed  Google Scholar 

  139. Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012;54 Suppl 1:S73–8.

    CAS  PubMed  Google Scholar 

  140. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012;67:715–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  141. Spiess B, Buchheidt D, Baust C, et al. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol. 2003;41:1811–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  142. Stanzani M, Battista G, Sassi C, et al. Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clin Infect Dis. 2012;54:610–6.

    PubMed  Google Scholar 

  143. Suzuki HI, Asai T, Tamaki Z, Hangaishi A, Chiba S, Kurokawa M. Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia. Haematologica. 2008;93:469–70.

    PubMed  Google Scholar 

  144. Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13:R15.

    PubMed Central  PubMed  Google Scholar 

  145. Tada K, Kurosawa S, Hiramoto N, Okinaka K, Ueno N, Asakura Y, Kim SW, Yamashita T, Mori SI, Heike Y, Maeshima AM, Tanosaki R, Tobinai K, Fukuda T. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant. 2013;48:74–9.

    CAS  PubMed  Google Scholar 

  146. Thomas Jr CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487–98.

    CAS  PubMed  Google Scholar 

  147. Torres HA, Aguilera EA, Mattiuzzi GN, et al. Characteristics and outcome of Respiratory Syncytial Virus infection in patients with leukemia. Haematologica. 2007;92:1216–23.

    PubMed  Google Scholar 

  148. Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50:1051–3.

    PubMed Central  PubMed  Google Scholar 

  149. Vehreschild JJ, Böhme A, Buchheidt D, et al. A double-blind trial on prophylactic voriconazole or placebo during induction chemotherapy for acute myelogenous leukaemia. J Infect. 2007;55:445–9.

    PubMed  Google Scholar 

  150. Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol. 2008;9:982–92.

    PubMed  Google Scholar 

  151. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with haematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–44.

    Google Scholar 

  152. Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs. 1994;48:199–226.

    CAS  PubMed  Google Scholar 

  153. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.

    CAS  PubMed  Google Scholar 

  154. Weisser M, Rausch C, Droll A, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis. 2005;41:1143–9.

    CAS  PubMed  Google Scholar 

  155. White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med. 2000;161:723–9.

    CAS  PubMed  Google Scholar 

  156. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis. 2006;42:479–86.

    CAS  PubMed  Google Scholar 

  157. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis. 2005;192:1061–5.

    PubMed Central  PubMed  Google Scholar 

  158. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin- resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003;124:1789–97.

    CAS  PubMed  Google Scholar 

  159. Zihlif M, Khanchandani G, Ahmed HP, Soubani AO. Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol. 2005;78:94–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Charlottenstrasse 72, D-14467, Potsdam, Germany

    Georg Maschmeyer

Authors
  1. Georg Maschmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg Maschmeyer .

Editor information

Editors and Affiliations

  1. Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany

    Georg Maschmeyer

  2. Department of Infectious Diseases, Infection Control and Employee Health, M.D. Anderson Cancer Center University of Texas, Houston, Texas, USA

    Kenneth V.I. Rolston

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maschmeyer, G. (2015). Pulmonary Complications. In: Maschmeyer, G., Rolston, K. (eds) Infections in Hematology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44000-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44000-1_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43999-9

  • Online ISBN: 978-3-662-44000-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation